This activity, presented by Dr. Marc A. Riedl, highlights recently updated HAE clinical practice guidelines, treatment advances, and emerging therapies for HAE. Dr. Riedl discusses how to distinguish CVID from other immunodeficiencies as well as immunoglobulin replacement therapy and emerging targeted therapies for CVID. Learners will gain insight on optimizing individualized patient care and considerations for improving quality of life for patients with HAE and CVID.
Upon successful completion of this educational activity, participants should be better able to:
Professor of Medicine
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief & Training Program Director
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources